Sign in

Bryan White, PharmD, FIDSA, BCIDP

@bryanpwhite.bsky.social
662 followers 598 following 54 posts

ID Pharmacist and PGY2 ID RPD in OKC at University of Oklahoma Medical Center

PostsRepliesMedia
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 26/05/2025
Totally agree. Trainees have a bunch of energy/enthusiasm. They often overcommit themselves to things. Having mentors advise on what to say no to is important.
010
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 12/04/2025
Excited to hear more details about the SNAP and CloCeBa trials for MSSA bacteremia being presented at ESCMID this afternoon. Looks like a win for team cefazolin. It will be practice changing with the current variations in practice for treating MSSA BSI. #ESCMID
042
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 04/04/2025
It builds on a previous paper by Crass and Pai which derived an equation for vancomycin AUC dosing in obese patients. academic.oup.com/ofid/advance...
academic.oup.com
010
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 04/04/2025
Our new paper on vancomycin AUC dosing in obesity is out. It showed decreased AKI in obese patients using AUC dosing as compared to trough dosing. Rates of AKI were lower in the AUC group compared to the trough group (11.3% versus 25.2%, p<0.001). This work was led by Corey Guidry .
academic.oup.com
143
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 20/03/2025
The PGY2 in ID at OU didn’t match and is going into phase 2. Please help spread the word! pharmacy.ouhsc.edu/programs/res...
pharmacy.ouhsc.edu
Infectious Diseases - OU College of Pharmacy
022
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 19/03/2025
📌
000
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 02/03/2025
It can be done but readmission and complication rates are high. pubmed.ncbi.nlm.nih.gov/33846129/
pubmed.ncbi.nlm.nih.gov
Experience with Liposomal Amphotericin B in Outpatient Parenteral Antimicrobial Therapy - PubMed
Outpatient parenteral antimicrobial therapy (OPAT) is a safe, effective, and convenient treatment strategy for patients receiving intravenous antimicrobials in the outpatient setting; however, data ar...
020
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Joseph Sassine @josephsassinemd.bsky.social · 11/02/2025
Excited to launch new tracks in our 2-year ID fellowship program @ou.edu starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care. Tracks come with option for 12-credit certificates, covered by the program: medicine.ouhsc.edu/academic-dep... 🧵 #IDSky #TxID
medicine.ouhsc.edu
Curriculum
131
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 09/02/2025
Yeah, we just two level trapezoidal pk. It really improved target attainment and AKI in our obese patients. We have a paper under review with our results.
010
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 09/02/2025
Has anyone been using dalba as 12 weeks of treatment for PJI as per Daptio? Any recs or papers on this would be helpful. #IDsky
100
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 01/02/2025
Kinda of a crazy night. Went out for ice cream and ran into Oklahoma’s US senator, James Lankford. Talked for 2 minutes about RFK. Nice conversation with a thoughtful politician. #IDsky
140
Reposted by Bryan White, PharmD, FIDSA, BCIDP
raizdon.bsky.social @raizdon.bsky.social · 01/02/2025
PLEASE SHARE WIDELY #medsky #IDsky #obgynsky #pedsky CDC STI treatment guidelines have been taken down. They are archived here 👇 web.archive.org/web/20250131...
web.archive.org
Site Index
STIs are common. Many are curable - all are preventable.
0137
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Joseph Marcus @josephmarcusid.medsky.social · 31/01/2025
Post-hoc analysis of 📷 📷 study in MSSA/MRSA bacteremia: Persistent fever = indicator for complicated infection Fever on Day 4️⃣: aOR (3.7 (95% CI: 1.58-8.67)) mortality Fever on Day 7️⃣: aOR: (8.78 (95% CI: 2.78-27.7) 🚫 assn between ⬆️CRP/WBC and mortality #IDSky academic.oup.com/ofid/advance...
academic.oup.com
Association of daily body temperature, white blood cell count, and C-reactive protein with mortality and persistent bacteremia in patients with Staphylococcus aureus bacteremia: a post-hoc analysis of...
AbstractIntroduction. Classification of patients with Staphylococcus aureus bacteremia (SAB) as complicated versus uncomplicated is based on a combination
23714
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 18/01/2025
Yeah, that would be a bargain. I’ve dropped some of them over the years. They aren’t cheap.
110
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Liv Swonger, PharmD @queerpharmacist.bsky.social · 07/01/2025
There is a director of pharmacy position open at Bartlett Regional Hospital in Juneau, Alaska. Oversees ~25 rx employees in a 55 bed hospital in Alaska's capital and largest town in Southeast Alaska. I work there several times a year, happy to answer any questions. Spread far and wide!
243
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 07/01/2025
I don’t. My Merck contacts didn’t know.
010
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 04/01/2025
This time of the year is exciting as a RPD to review the packets from great candidates who are excited to learn more. #pharmsky
020
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 03/01/2025
I could go either way. I’d maybe offer a fellows project and see if they liked it.
110
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 31/12/2024
Yeah there is a paper or two on this topic that are currently under review.
000
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 30/12/2024
I do QID. Better exposures based on this study. pubmed.ncbi.nlm.nih.gov/30908107/
pubmed.ncbi.nlm.nih.gov
Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections - PubMed
Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections
021
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 30/12/2024
I laugh loudly to movies on planes too frequently.
010
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Tired Pharmacist @tiredpharmacist.bsky.social · 24/12/2024
Pharmacy fun fact! You need to be very careful when handling metronidazole. It’s flagyl #medsky #pharmsky
291
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 29/12/2024
They pushed the dates back for this year, but yeah the format could be updated.
010
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 29/12/2024
Yeah, we dose adjust up all the time. Obese patients do worse (pubmed.ncbi.nlm.nih.gov/32062851/) with candidemia. Obese patients have lower exposures than normal weight patients (pubmed.ncbi.nlm.nih.gov/37272474/). There hasn’t been data that I’m aware of showing improved outcomes with higher doses
pubmed.ncbi.nlm.nih.gov
Impact of Obesity in Patients with Candida Bloodstream Infections: A Retrospective Cohort Study - PubMed
Worse clinical outcomes were observed for obese versus non-obese patients. Further clinical research is warranted.
010
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 28/12/2024
I liked lake george NY.
210
Reposted by Bryan White, PharmD, FIDSA, BCIDP
JAC-AMR @jac-amr.bsky.social · 27/12/2024
A retrospective cohort study of Gram-negative BSIs in ICU shows fever, lack of source control and time to repeat follow-up blood culture (FUBC) as risk factors for repeat positive FUBC: doi.org/10.1093/jacamr/dlae144 #JACAMRNews @bryanpwhite.bsky.social
doi.org
Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemia
AbstractObjectives. To evaluate the utility of follow-up blood cultures (FUBCs) for Gram-negative bloodstream infection (BSI) in ICU patients and identify
032
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 23/12/2024
If valve cultures are negative, then I’d go by clearance of blood cultures. If valve cultures are positive, I’d restart the clock.
1110
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 22/12/2024
📌
010
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 18/12/2024
📌
000
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Erin McCreary, PharmD @erinmccreary.bsky.social · 17/12/2024
UPMC Western Maryland is looking for a full time stewardship pharmacist. Come work with a truly amazing local team and have system support from Tina Khadem, myself, and ~40 other pharmacists! (also - no holidays, no weekends!) #idsky #amssky #pharmsky #medsky sidp.mcjobboard.net/jobs/173869
sidp.mcjobboard.net
Infectious Disease Clinical Pharmacist Specialist
UPMC Western Maryland is seeking a highly motivated Infectious Disease Clinical Pharmacist to lead its Antimicrobial Stewardship Program. UPMC Western Maryland is a 224-bed nonprofit, acute care hospi...
1176
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 17/12/2024
Yeah, Merck funded it but didn’t have any say in results being published. The funding for these retrospective studies is not a ton.
000
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 17/12/2024
Contrasted by this study showing higher ceftolozane/tazo resistance development in MDR pseudo infections. pubmed.ncbi.nlm.nih.gov/39230311/
pubmed.ncbi.nlm.nih.gov
Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam - PubMed
Few studies compare outcomes of patients with difficult-to-treat resistance (DTR) <i>Pseudomonas aeruginosa</i> infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam. A multicent...
120
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 17/12/2024
🔥🆕️CACTUS Multi center real world data on ceftaz/avi vs ceftol/tazo for MDR PsA bacteremia or pneumonia Overall similar clinical success including mortality, recurrent infection & resistance #idsky #EMIMCC #medsky www.thelancet.com/journals/lan...
thelancet.com
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
Treatment with ceftolozane–tazobactam resulted in higher rates of clinical success compared with ceftazidime–avibactam for invasive infections due to multidrug-resistant P aeruginosa. Differences were driven by improved response rates for patients with pneumonia who were treated with ceftolozane–tazobactam. There were no significant differences between study groups with respect to all-cause mortality; treatment-emergent resistance was common with both agents.
1229
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 15/12/2024
Yeah, there is some resistance benchmarks. We haven’t done much with them yet. www.youtube.com/watch?v=qEmK...
youtube.com
NHSN Antimicrobial Resistance (AR) Option Benchmark Metrics: SRIR and pSIR
YouTube video by Centers for Disease Control and Prevention (CDC)
110
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Joseph Sassine @josephsassinemd.bsky.social · 15/12/2024
First post on #IDSky We have an ID fellowship opening at the University of Oklahoma @ou.edu, starting July 2025. Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with! DM me for details! medicine.ouhsc.edu/academic-dep...
medicine.ouhsc.edu
Fellowship Opportunities
03315
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 13/12/2024
academic.oup.com/ofid/advance...
academic.oup.com
Histoplasmosis Associated with Bat Guano Exposure in Cannabis Growers: Two Cases
Abstract. Histoplasma capsulatum is a pathogenic dimorphic fungus with evolving epidemiology. Initially described as endemic to the Ohio and Mississippi ri
130
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Julie Ann Justo @juliejusto.bsky.social · 13/12/2024
I’m in! 🙋🏻‍♀️ Who else in #IDsky #Pharmsky #AMSsky is going? @sidpharm.bsky.social
041
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 13/12/2024
We are.
010
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 13/12/2024
📌
000
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 13/12/2024
We don’t use it that often. We should use it more often.
020
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Sanford Guide @sanfordguide.bsky.social · 12/12/2024
Pre-exposure prophylaxis (PreP) is an effective strategy to prevent HIV infection. However, lack of adherence to daily oral therapy is a major reason for failure in preventing HIV infection. Read about two large RCTs on twice-yearly lenacapavir buff.ly/3OTO5CE #HIVsky #IDsky
073
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 13/12/2024
We do on all here. It was a decision from a while ago mainly for infection control.
020
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 13/12/2024
Yeah, i try to provide some papers on how to peer review. I have some I can send you if you want. I’ll have them write a review down to get their ideas on paper.
020
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Athena Hobbs @athenalvhobbs.bsky.social · 12/12/2024
Having a blast learning at ASHP (with @bryanpwhite.bsky.social) and exploring NOLA-Sazerac house, City Park lights
Two pharmacists at a conferenceFriends sitting on a trainChristmas tree under Spanish mossRecipe for Sazerac drink
051
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Justin Moore @moorewjustin.bsky.social · 08/12/2024
Great ID expert session on optimal invasive Candidiasis diagnostics & mgmt from @bryanpwhite.bsky.social & Daniel Chastain at #ASHP24
051
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Justin Moore @moorewjustin.bsky.social · 10/12/2024
Wonderful insight from @athenalvhobbs.bsky.social & @bryanpwhite.bsky.social on oral therapies for bloodstream infections due to a urinary source at ASHP! Pop girlies & ID unite for the TSwift support of PO! 💞💊 #ASHP24
271
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Sébastien Poulin @sebpoule.bsky.social · 05/12/2024
The « meme master » is here @iddocadi.bsky.social (IDdocAdi, Adi S. Shah) #IDsky #Medsky
media.tenor.com
a man with long hair and a beard is standing in front of a cloudy sky .
ALT: a man with long hair and a beard is standing in front of a cloudy sky .
3214
Reposted by Bryan White, PharmD, FIDSA, BCIDP
Lisa Dumkow, PharmD, BCIDP, FIDP @lisaidpharmd.bsky.social · 02/12/2024
🚨📣 @sidpharm.bsky.social the Board and Programs Committee want to hear from you! Please take 2 minutes to fill out the member survey for 2025 planning before Friday: www.cognitoforms.com/SIDP1/_2025S...
https://www.cognitoforms.com/SIDP1/_2025SocietyPlanningSurvey
086
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 29/11/2024
Black Friday special!
020
Bryan White, PharmD, FIDSA, BCIDP @bryanpwhite.bsky.social · 25/11/2024
📌
100